<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2711222941
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        OFLAM 50MG GRANULES FOR ORAL SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC POTASSIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Granules for oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Sachet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        20.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>OFLAM GRANULES is a prescription medicine used to treat migraine attacks in adults. It does not prevent or lessen the number of migraines you have, and it is not for other types of headaches. OFLAM GRANULES contains diclofenac potassium (a Non-Steroidal Anti-Inflammatory Drug or NSAID).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Some people <strong>MUST NOT </strong>take Oflam&reg; Granules. Talk to your doctor if:</p><ul><li>You think you may be allergic to diclofenac potassium, aspirin, ibuprofen or any other NSAID, or to any of the other ingredients of Oflam&reg; Granules. (These are listed at the end of the leaflet.) Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reaction</li><li>You have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces)</li><li>&nbsp;You have had stomach or bowel problems after you have taken other NSAIDs</li><li>&nbsp;You have severe heart, kidney or liver failure</li><li>&nbsp;If you have established heart disease and/or cerebrovascular disease e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages</li><li>If you have or have had problems with your blood circulation (peripheral arterial disease)</li><li>&nbsp;You are more than six months pregnant.</li></ul><p><strong>You should also ask yourself these questions before taking Oflam&reg; Granules:</strong></p><ul><li>Do you suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&#39;s disease?</li><li>Do you have kidney or liver problems, or are you elderly?</li><li>Do you have a condition called porphyria?</li><li>Do you suffer from any blood or bleeding disorder? If you do, your doctor may ask you to go for regular check-ups while you are taking these sachet.</li><li>Have you ever had asthma?</li><li>Are you breast-feeding?</li><li>Do you have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides</li><li>&nbsp;Do you have heart problems, or have you had a stroke, or do you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes, or high cholesterol or are a smoker)?</li><li>Do you have diabetes</li><li>Do you smoke</li><li>Do you have Lupus (SLE) or any similar condition?</li></ul><p><strong>If the answer to any of these questions is YES, discuss your treatment with your doctor or pharmacist because Oflam&reg; Granules might not be the right medicine for you.</strong></p><p><strong>ARE YOU TAKING OTHER MEDICINES?</strong></p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are taking any of the following:</p><ul><li>Medicines to treat diabetes</li><li>Anticoagulants (blood thinning tablets like warfarin)</li><li>Diuretics (water tablets)</li><li>Lithium (used to treat some mental problems)</li><li>Methotrexate (for some inflammatory diseases and some cancers)</li><li>Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after transplants)</li><li>Trimethoprim (a medicine used to prevent or treat urinary tract infections)</li><li>Quinolone antibiotics (for infections)</li><li>Any other NSAID or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or ibuprofen</li><li>Mifepristone (a medicine used to terminate pregnancy)</li><li>Cardiac glycosides (for example digoxin), used to treat heart problems</li><li>Medicines known as SSRIs used to treat depression</li><li>Oral steroids (an anti-inflammatory drug)</li><li>Medicines used to treat heart conditions or high blood pressure, for example beta-blockers or ACE inhibitors.</li><li>Voriconazole (a medicine used to treat fungal infections).</li><li>Phenytoin (a medicine used to treat seizures)</li><li>Colestipol/cholestyramine (used to lower cholesterol)</li></ul><p>Always tell your doctor or pharmacist about all the medicines you are taking. <em>This means medicines you have bought yourself as well as medicines on prescription from your doctor.</em></p><p><strong>Pregnancy</strong></p><ul><li>Are you pregnant or planning to become pregnant? Although not common, abnormalitie have been reported in babies whose mothers have taken NSAIDs during pregnancy. You should not take Oflam&reg; Granules during the last 3 months of pregnancy as it may the baby&rsquo;s circulation.</li><li>Are you trying for a baby? Taking Oflam&reg; Granules may make it more difficult to conceive. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</li></ul><p><strong>Will there be any problems with driving or using machinery?</strong></p><p>Very occasionally people have reported that Oflam&reg; Granules have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p><strong>Other special warnings</strong></p><ul><li>You should take the lowest dose of Oflam&reg; for the shortest possible time, particularly if you are underweight or elderly.</li><li>There is a small increased risk of heart attack or stroke when you are taking any medicine like Oflam&reg;. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</li><li>&nbsp;Whilst you are taking these medicines your doctor may want to give you a check-up from time to time.</li><li>If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</li><li>Because it is an anti-inflammatory medicine, Oflam&reg; may reduce the symptoms of infection, for example, headache and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking Oflam&reg;.</li></ul><p><strong>Important information about some of the ingredients of Oflam&reg; sachet</strong></p><p>This medication may contain aspartame. If you have phenylketonuria (PKU) or any other condition that requires you to limit/avoid aspartame (or phenylalanine) in your diet, ask your doctor or pharmacist about using this medication safely.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Take OFLAM GRANULES exactly as your healthcare provider tells you to take it.</p><p>Take 1 dose of OFLAM GRANULES to treat your migraine headache:</p><ul><li>remove one single dose sachet</li><li>open sachet only when you are ready to use it</li><li>empty contents of sachet into 1 to 2 ounces (2 to 4 tablespoons) of water</li><li>mix well and drink the water and powder mixture</li><li>throw away empty sachet in a safe place and out of the reach of children</li><li>do not take more OFLAM GRANULES than directed by your healthcare provider. In case of overdose, get medical help.</li></ul><p><strong>Take the granules with or after food</strong></p><p>Taking Oflam&reg; Granules with food may cause a reduction in effectiveness compared to taking Oflam&reg; Granules on an empty stomach</p><p><strong>The usual doses are:</strong></p><p>Oflam&reg; Granules is available in individual sachets each designed to deliver a 50 mg dose when mixed in water.</p><p><strong>Adults </strong>: Take 1 dose of Oflam&reg; Granules (sachet) to treat your migraine headache</p><p>They are not recommended for the treatment of migraine in children younger than 18 years old.</p><p><strong>What if you forget to take a dose?</strong></p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, though, just take the next dose and forget about the one you missed. Do not double up on the next dose to make up for the one missed.</p><p><strong>What if you take too many sachets?</strong></p><p>If you, or anyone else, accidentally takes too much, tell your doctor or your nearest hospital casualty department. Take your medicine pack with you so that people can see what you have taken.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Oflam&reg; are suitable for most people, but, like all medicines, they can sometimes cause side effects. Side effects may be minimised by using the lowest effective dose for the shortest duration necessary.</p><p><strong><u>Some side effects can be serious</u></strong></p><p>Stop taking Oflam&reg; and tell your doctor straight away if you notice:</p><ul><li>Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick)</li><li>Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black, tarry faeces</li><li>Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering</li><li>Wheezing or shortness of breath (bronchospasm)</li><li>Swollen face, lips, hands or fingers</li><li>Yellowing of your skin or the whites of your eyes</li><li>Persistent sore throat or high temperature</li><li>An unexpected change in the amount of urine produced and/or its appearance.</li></ul><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor.</p><p><strong><u>The side effects listed below have also been reported.</u></strong></p><p><strong>Common side effects (These may affect between 1 and 1 in 10 in every 100 patients:</strong></p><ul><li>Stomach pain, heartburn, nausea, vomiting, diarrhoea, indigestion, wind, loss of appetite</li><li>Headache, dizziness, vertigo</li><li>Skin rash or spots</li><li>Raised levels of liver enzymes in the blood.</li></ul><p><strong>Rare side effects (These may affect between 1 in every 1000 to 1 in every 10,000 patients):</strong></p><ul><li>Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly)</li><li>Gastritis (inflammation, irritation or swelling of the stomach lining)</li><li>Vomiting blood</li><li>Diarrhoea with blood in it or bleeding from the back passage</li><li>Black, tarry faeces or stools</li><li>Drowsiness, tiredness</li><li>Hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness)</li><li>Skin rash and itching</li><li>&nbsp;Fluid retention, symptoms of which include swollen ankles</li><li>Liver function disorders, including hepatitis and jaundice.</li></ul><p><strong>Very rare side effects (These may affect less than 1 in every 10,000 patients):</strong></p><p><strong><u>Effects on the nervous system: </u></strong>Tingling or numbness in the fingers, tremor, visual disturbances such as blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental disorders, , disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck, disturbances in sensation.</p><p><strong><u>Effects on the stomach and digestive system:</u> </strong>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or lips, taste changes, lower gut disorders (including inflammation of the colon or worsening of ulcerative colitis or Crohn&rsquo;s disease).</p><p><strong><u>&nbsp;Effects on the heart, chest or blood:</u> </strong>Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood pressure), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), heart disorders, including congestive heart failure, or heart attack, blood disorders (including anaemia).</p><p><strong><u>Effects on the liver or kidneys:</u> </strong>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine.</p><p><strong><u>&nbsp;Effects on skin or hair:</u> </strong>Serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight. Hair loss.</p><p><strong><u>Other side effects that have also been reported include: </u></strong>Inflammation of the pancreas, impotence, facial swelling, inflammation of the lining of the brain (menigitis), stroke, throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye.</p><p>Medicines such as diclofenac may be associated with a small increased risk of heart attack or stroke. Do not be alarmed by this list - most people take Oflam&reg; without any problems.</p><p>If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store in a dry place, below 30&deg;C. Keep the granules in their original pack.</p><p>Keep out of the reach and sight of children.</p><p>Do not take Oflam&reg; Granules after the expiry date which is printed on the outside of the pack.</p><p>If your doctor tells you to stop taking the granules, please take any unused quantity back to your pharmacist to be destroyed. Do not throw them away with your normal household water or waste. This will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Oflam&reg; Granules 50 mg (Diclofenac Potassium for Oral Solution) is supplied as one sachet. Each individual sachet is designed to deliver a dose of 50 mg diclofenac potassium when mixed in water.</p><p>The granules also contain the inactive ingredients: Sugar Fitzmilled; Mannitol; Sodium Saccharine; Aspartame; Potassium Bicarbonate; Peppermint Powder Flavor; Aniseed Powder Flavor; Alcohol 95</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The granules come into a sachet each box containing 10 sachets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder and Manufacturer</strong></p><p>Jazeera Pharmaceutical Industries (JPI)</p><p>Riyadh, Saudi Arabia, 11666 Riyadh, P.O.Box 106229</p><p>Phone No.: +966-11-207-8172</p><p>Fax: +966-11-207-8097</p><p>E-mail: <u>medical@jpi.com.sa</u></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 04/2014, version 1.1
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">حبيبات أوفلام&reg; دواء يستخدم&nbsp;لعلاج نوبات الصداع النصفي لدى البالغين. فإنه لا يمنع أو يقلل من عدد نوبات الصداع النصفي لديك، ولا يستخدم للأنواع الأخرى من الصداع. حبيبات أوفلام حبيبات&reg; أوفلام&nbsp;تحتوي على ديكلوفيناك البوتاسيوم (مضادات الإلتهاب الغير ستيرويدية ).&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;بعض الأشخاص <strong>لا يجب</strong> أن تأخذ حبيبات أوفلام&reg;&nbsp;اخبر إلى طبيك إذا:&nbsp;</p><ul><li>كنت تعتقد أن لديك حساسية من ديكلوفيناك البوتاسيوم، والأسبرين والايبوبروفين أو لأي الأدوية غير الستيرويدية&nbsp;المضادة للالتهاب، أو إلى أي من المكونات الأخرى من لحبيبات أوفلام&nbsp;&reg;.(مدرجة في نهاية النشرة.)&nbsp;مؤشرات على رد فعل فرط الحساسية وتشمل تورم في الوجه والفم (وذمة وعائية)، ومشاكل في التنفس، وسيلان الأنف، وطفح جلدي أو أي رد فعل بنوع آخر من انواع الحساسية .</li><li>لديك الآن، أو من أي وقت مضى، قرحة في المعدة أو الإثنى أو نزيف في الجهاز الهضمي (وهذا يمكن أن تشمل الدم&nbsp;في القيء، والنزيف عند إفراغ الأمعاء، ودماء جديدة في البراز أو أسوداده، او براز قطراني</li><li>كان لديك مشاكل في المعدة أو الأمعاء بعد استخدام اي من المسكنات الأخرى</li><li>لديك فشل حاد في القلب، الكلى أو الكبد</li><li>إذا كنت مصاب بأمراض القلب و / أو الأمراض القلبية الوعائية على سبيل المثال إذا كنت قد اصبت بنوبة قلبية&nbsp;والسكتة الدماغية والسكتة الدماغية المصغرة (TIA) أو انسداد الأوعية الدموية إلى القلب أو الدماغ أو عملية لإزالة أو تجنب &nbsp;مثل هذا الإنسداد</li><li>إذا كان لديك سابقا او حاليا مشاكل مع الدورة الدموية (أمراض الشرايين الطرفية)</li><li>كنتي حاملا لأكثر من ستة اشهر.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>يجب عليك أن تسأل نفسك هذه الأسئلة قبل استعمال أوفلام</strong></li><li>هل تعاني من أي اضطرابات في المعدة أو الأمعاء بما في ذلك التهاب القولون التقرحي أو مرض كرون؟</li><li>هل لديك مشاكل في الكلى أو الكبد، أو أنت من المسنين؟</li><li>هل لديك حالة تسمى البورفيريا؟</li><li>هل تعاني من أي دم أو اضطراب نزفي؟ إذا كانت الإجابة بنعم، فإن طبيبك قد يطلب منك أن تذهب لعمل فحوص منتظمة بشكل دوري في حين كنت تأخذ هذه الدواء.</li><li>هل كان لديك في أي وقت مضى الربو؟</li><li>أنتي ترضعين رضاعة طبيعية؟</li><li>هل لديك الذبحة الصدرية، وجلطات الدم، وارتفاع ضغط الدم، او ارتفاع الكوليسترول أو الدهون الثلاثية</li><li>هل لديك مشاكل في القلب، أو قد اصبت بسكتة دماغية، أو تعتقد أنك قد تكون في معرض بخطر الإصابة بهذه الحالات (على سبيل المثال، إذا كان لديك ارتفاع ضغط الدم، والسكري، أو ارتفاع الكوليسترول في الدم أو مدخنا)؟</li><li>هل تعاني من مرض السكر؟</li><li>هل تدخن؟</li><li>هل لديك مرض الذئبة&nbsp;(SLE) أو أي حالة مشابهة؟ &nbsp;</li></ul><p><strong>إذا كانت الإجابة على أي من هذه الأسئلة هو نعم، ناقش طبيبك أو الصيدلي قبل استخدام أوفلام&nbsp;قد لا يكون هو الدواء المناسب لك<br />التداخلات الدوائية من أخذ هذا المستحضر مع أي ادوية اخرى او اعشاب او مكملات غذائية</strong></p><p>يمكن لبعض الأدوية تتداخل مع العلاج. أخبر طبيبك أو الصيدلي إذا كنت تأخذ أي مما يلي:</p><ul><li>الأدوية لعلاج مرض السكري</li><li>مضادات التخثر (أقراص تخفيف الدم مثل الوارفارين)</li><li>مدرات البول (أقراص الماء)</li><li>&nbsp;الليثيوم (التي تستخدم لعلاج بعض المشاكل النفسية)</li><li>الميثوتريكسيت (لبعض الأمراض الالتهابية وبعض أنواع السرطان)</li><li>السيكلوسبورين وتاكروليموس (التي تستخدم لعلاج بعض الأمراض الالتهابية وبعد زراعة الأعضاء)</li><li>&nbsp;ميثوبريم (دواء يستخدم لمنع أو علاج التهابات المسالك البولية)</li><li>المضادات الحيوية الكينولون (للعدوى)</li><li>أي مستحضر آخر مضادات الالتهاب الغير ستيرويدية&nbsp;(NSAIDs) ، او أي من مثبطات كوكس- 2 (COX-2)على سبيل المثال الأسبرين أو الإيبوبروفين</li><li>الميفيبريستون (دواء يستخدم لإنهاء الحمل)</li><li>جليكوسيدات القلب (على سبيل المثال الديجوكسين)، وتستخدم لعلاج مشاكل في القلب</li><li>الأدوية المعروفة باسم اس اس ار اي تستخدم لعلاج الاكتئاب</li><li>&nbsp;الستيرويدات عن طريق الفم (عقار مضاد للالتهابات)</li><li>الأدوية المستخدمة لعلاج أمراض القلب أو ارتفاع ضغط الدم، على سبيل المثال حاصرات بيتا أو مثبطات الإنزيم المحول للأنجيوتنسين.</li><li>فوريكونازول (دواء يستخدم لعلاج الالتهابات الفطرية).</li><li>الفينيتوين (دواء يستخدم لعلاج النوبات التشنجية)</li><li>كوليستيبول / الكولسترامين (التي تستخدم لخفض الكولسترول)</li></ul><p><strong>اخبر طبيبك أو الصيدلي دائما عن جميع الأدوية التي تتناولها، وهذا يعني جميع الأدوية التي قد اشتريتها من نفسك وكذلك الأدوية التي حصلت عليها&nbsp;بوصفة طبية من الطبيب.</strong></p><p><strong>الحمل والرضاعة</strong></p><ul><li>هل أنت حامل أو تخططين لتصبحي حاملا؟ بالرغم من ذلك فإنه&nbsp;تم تسجيل حالات غير شائعة بحدوث شذوذ عند&nbsp;&nbsp;الاطفال الذين استخدمت امهاتهم المسكنات أثناء الحمل. يجب أن لا تأخذ أوفلام خلال الثلاثة أشهر الأخيرة من الحمل.</li><li>هل تحاولين الإنجاب؟ أخذ أوفلام&nbsp;قد تجعل الأمر أكثر صعوبة لحدوث الحمل. يجب عليك التحدث مع طبيبك إذا &nbsp;كنتي تخططين لتصبحي حاملا، أو إذا كان لديك مشاكل في الإنجاب.</li></ul><p><strong>&nbsp;تأثير أوفلام &reg; على القيادة او استخدام الآلات</strong><br />ذكرت التقارير المسجلة من الأشخاص الذين يستخدمون أوفلام&reg;&nbsp;انه&nbsp;من الغالب جدا الشعور بالدوار، والتعب أو النعاس. كما تم الإبلاغ عن مشاكل مع البصر. إذا كنت تعاني من ذلك، يجب عدم قيادة السيارات او تشغيل الآلات.</p><p><strong>تحذيرات خاصة أخرى</strong></p><ul><li>&nbsp;يجب أن تأخذ أقل جرعة من أوفلام&nbsp;لأقصر وقت ممكن، لا سيما إذا كنت تعاني من نقص الوزن أو كنت من كبار&nbsp; السن.</li><li>هناك خطر بسيط من تزايد الإصابة بنوبة قلبية أو السكتة الدماغية اذا كنت تأخذ أي دواء مثل أوفلام&nbsp;و ترتفع نسبة&nbsp; الخطر إذا كنت تأخذ جرعات عالية لفترة طويلة. اتبع دائما تعليمات الطبيب كمية الإستخدام ومدته&nbsp;</li><li>في حين كنت تأخذ هذه الأدوية قد يرغب طبيبك فحصك من وقت لآخر.</li><li>إذا كان لديك تاريخ من مشاكل في المعدة عندما كنت تأخذ المسكنات، خاصة إذا كنت من كبار السن، يجب إخبار الطبيب فورا إذا لاحظت أي أعراض غير عادية.</li></ul><p>لأنه&nbsp;هو دواء مضاد للالتهابات،أوفلام&nbsp;&reg; قد يقلل أعراض الإصابة بالعدوى، على سبيل المثال؛ الصداع وارتفاع درجة الحرارة. إذا كنت&nbsp;تشعر بتوعك وبحاجة إلى مراجعة الطبيب، تذكر أن تقول له&nbsp;أو لها بإستخدامك لأوفلام<br /><strong>معلومات هامة حول بعض العناصر المكونة لحبيبات أوفلام&reg;</strong><br />قد يحتوي هذا الدواء الأسبارتام. إذا كان لديك بيلة الفينيل كيتون(PKU)&nbsp;أو أي حالة أخرى تتطلب منك أن تحد / تجنب الأسبارتام (أو الفينيل ألانين) في النظام الغذائي الخاص بك، إسأل طبيبك أو الصيدلي حول استخدام هذا الدواء بأمان.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم حبيبات أوفلام تماما كما اخبرك طبيبك ان تأخذه .<br />يجب اخذ جرعة واحدة (مغلف واحد) من حبيبات أوفلام&nbsp;لعلاج الصداع النصفي لديك:</p><ul><li>قم بأخذ مغلف واحد من الكرتون</li><li>&nbsp;قم بفتح المغلف فقط عندما تصبح مستعدا لاستخدامه</li><li>افرغ محتويات المغلف الواحد في 1&nbsp;- 2 أونصه (2-4&nbsp;ملعقة طعام) من الماء &nbsp;</li><li>تخلط جيدا ويشرب خليط الماء والحبيبات المذابة</li><li>نرمي المغلف الفارغ في مكان آمن وبعيدا عن متناول الأطفال</li><li>لا تأخذ اكثر من مغلفات أوفلام&nbsp;التي وصفها لك الطبيب. في حال الجرعة الزائدة، يجب الحصول على المساعدة الطبية.&nbsp;</li></ul><p><strong>تأخذ حبيبات مع أو بعد الطعام</strong><br />&nbsp;أخذ حبيبات أوفلام&nbsp;مع الطعام قد يسبب انخفاضا في فعاليتة مقارنة مع اخذه على معدة فارغة.</p><p><strong>الجرعات المعتادة هي:</strong></p><p>حبيبات أوفلام&nbsp;متوفرة داخل مغلفات كل مغلف من هذه المغلفات مجهز لتقديم جرعة 50 ملغ عند مزجه&nbsp;في الماء.</p><p><strong>البالغين</strong>: خذ جرعة واحدة من حبيبات أوفلام( مغلف واحد) لعلاج صداعك النصفي&nbsp;<br />لا ينصح بها لعلاج الصداع النصفي لدى الأطفال الذين تقل أعمارهم عن 18 سنة.</p><p><strong>&nbsp;نسيان تناول جرعة أوفلام</strong><br />إذا كنت قد نسيت أن تأخذ جرعة، تأخذ واحدة في أقرب وقت تتذكر. إذا كان قد حان الوقت تقريبا لتناولك الجرعة التالية، قم بتناولها وانسى امر جرعتك المنسية. لا تضاعف الجرعة التالية تعويضا للجرعة المنسية.</p><p><strong>الجرعة الزائدة من أوفلام</strong><br />إذا كنت انت، أو أي شخص آخر، تناول الكثير من مغلفات أوفلام&nbsp;أخبر طبيبك أو أقرب قسم الطوارئ في المستشفى الخاص بك. اجلب معك حزمة الادوية الخاصة بك حتى يتمكن الناس من معرفة ما تناولته.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>أوفلام هي&nbsp;مناسبة لمعظم الناس، ولكن، مثل كل الأدوية، فإنها يمكن أن تتسبب في بعض الأحيان آثار جانبية. يمكن التقليل من الآثار الجانبية باستخدام أقل جرعة فعالة</p><p>لأقصر مدة لازمة.<br /><strong><u>بعض الآثار الجانبية يمكن أن تكون خطيرة</u></strong><br />توقف عن تناول&nbsp;&reg; أوفلام&nbsp; واخبر الطبيب على الفور إذا لاحظت:</p><ul><li>آلام في المعدة، عسر الهضم، وحرقة، والرياح، والغثيان (الشعور بالقئ) أو التقيؤ.</li><li>أي علامة من نزيف في المعدة أو الأمعاء، على سبيل المثال، عند إفراغ أمعائك، والدم في القيء أو أسوداد لونه,&nbsp;او براز اسود.</li><li>الحساسية التي يمكن أن تشمل الطفح الجلدي، والحكة، وكدمات، و مناطق حمراء مؤلمة، تقشير او نفط.</li><li>الصفير أو ضيق في التنفس (تشنج قصبي)</li><li>&nbsp;تورم الوجه، الشفاه، اليدين أو الأصابع</li><li>اصفرار الجلد أو في بياض عينيك</li><li>التهاب الحلق المستمر أو ارتفاع في درجة الحرارة</li><li>تغيير غير متوقع في كمية البول المنتجة و / أو مظهره.</li></ul><p>إذا لاحظت اصابتك بالكدمات بسهولة أكثر من المعتاد أو لديك التهاب الحلق أو التهابات متكررة، أخبر طبيبك.</p><p><u><strong>كما تم الإبلاغ عن الآثار الجانبية المذكورة أدناه:</strong></u><br /><strong>الآثار الجانبية شيوعا (قد تؤثر هذه بين 1 و 1 من 10 في كل 100 مريض):</strong></p><ul><li>آلام في المعدة، وحرقة، والغثيان، والتقيؤ، والإسهال، وعسر الهضم، الأرياح، وفقدان الشهية</li><li>الصداع، والدوخة، والدوار</li><li>طفح جلدي أو بقع</li><li>ارتفاع مستويات أنزيمات الكبد في الدم.</li></ul><p><strong>آثار جانبية نادرة (قد تؤثر هذه بين 1 في كل 1000 الى 1 في كل 10,000 مريضا):</strong></p><ul><li>قرحة المعدة أو النزيف (ذكرت التقارير انه&nbsp;كانت هناك حالات نادرة جدا أدت إلى الوفاة، وخاصة في كبار السن)</li><li>التهاب المعدة (التهاب، وتهيج أو تورم في بطانة المعدة)</li><li>التقيؤ دما</li><li>الإسهال مع الدم ، أو نزيف من الدبر</li><li>أسوداد، البراز او براز قطراني</li><li>النعاس، التعب</li><li>انخفاض ضغط الدم (انخفاض ضغط الدم، وأعراض قد تشمل الضعف، الدوخة أو الدوار الخفيف)</li><li>الطفح الجلدي والحكة</li><li>احتباس السوائل، والأعراض التي تشمل تورم الكاحلين</li><li>اضطرابات وظائف الكبد، بما في ذلك التهاب الكبد واليرقان.</li></ul><p><strong>آثار جانبية نادرة جدا (قد تؤثر هذه أقل من 1 في كل 10,000 مريضا):<br /><u>التأثيرات على الجهاز العصبي</u></strong>: وخز أو خدر في الأصابع، ورعاش، واضطرابات بصرية مثل عدم وضوح الرؤية أو ضعف، وفقدان أو ضعف السمع، طنين (رنين في الأذنين)، والأرق، والكوابيس، وتغيرات في المزاج، والاكتئاب، والقلق والاضطرابات النفسية ،،<br />والارتباك وفقدان الذاكرة،نوبات، والصداع جنبا إلى جنب مع الإنزعاج من الأضواء الساطعة ، والحمى، وتصلب الرقبة، واضطرابات في الإحساس.<br /><strong><u>الآثار على المعدة والجهاز الهضمي</u></strong>: الإمساك، والتهاب اللسان، وتقرحات الفم، والتهاب داخل الفم أو الشفتين، تغييرات في التذوق، واضطرابات القناة الهضمية السفلى (بما في ذلك التهاب في القولون أو تفاقم التهاب القولون التقرحي أو مرض كرون).<br /><strong><u>التأثيرات على القلب والصدر أو الدم</u></strong>: الخفقان (سريع أو عدم انتظام ضربات القلب)، وألم في الصدر وارتفاع ضغط الدم (ارتفاع ضغط الدم)، والتهاب الأوعية الدموية، والتهاب الرئة (التهاب رئوي)، واضطرابات القلب، بما في ذلك فشل القلب الاحتقاني، أو نوبة قلبية، واضطرابات الدم (بما في ذلك فقر الدم).<br /><strong><u>الآثار على الكبد أو الكلى</u></strong>: الكلى أو اضطرابات الكبد الحادة بما في ذلك فشل الكبد، وجود دم أو بروتين في البول.<br /><strong><u>الآثار على الجلد أو الشعر</u></strong>: الطفح الجلدي الشديد بما في ذلك متلازمة ستيفنز جونسون ومتلازمة لييل والطفح الجلدي التي يمكن أن يزداد سوءا بسبب التعرض لأشعة الشمس. فقدان الشعر.<br /><u><strong>الآثار الجانبية الأخرى التي أيضا تم الإبلاغ عنها و تشمل</strong></u>: التهاب البنكرياس، والعجز الجنسي، وتورم في الوجه، والتهاب بطانة الدماغ (التهاب السحاي)، والسكتة الدماغية، واضطرابات الحنجرة، والارتباك، والهلوسة، والشعور بالضيق (الشعور العام بعدم الارتياح)، والتهاب الأعصاب في العين.</p><p>الأدوية مثل ديكلوفيناك قد تترافق مع زيادة بسيطة من خطر الإصابة بأزمة قلبية او جلطة.</p><p>لا تندهش بهذه القائمة - معظم الناس تأخذ أوفلام&nbsp;دون أي مشاكل.</p><p>إذا اصبحت أي من الأعراض مزعجة، أو إذا لاحظت أي شيء آخر غير مذكور هنا، يرجى الذهاب ورؤية الطبيب. انه / انها قد تحتاج لتعطيك دواء مختلف.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تبقي بعيدا عن متناول وبصر الأطفال.</p><p>تخزينها في مكان جاف، أقل من 30 درجة مئوية. احفظ الحبيبات في مغلفها الأصلي.</p><p>لا تأخذ أوفلام&nbsp;بعد تاريخ انتهاء الصلاحية التي يتم طباعتها على السطح الخارجي للعلبة، وهو اليوم الأخير من ذلك الشهر.</p><p>لا ينبغي التخلص من الأدوية عن طريق مياه الصرف الصحي او النفايات المنزلية، اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجتها،وذلك لأن هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>حبيبات أوفلام&nbsp;50 ملغ (ديكلوفيناك البوتاسيوم للحل عن طريق الفم) تزود بداخل مغلفات فردية. تم تصميم كل مغلف فردي لتقديم جرعة من 50 ملغ ديكلوفيناك البوتاسيوم عند مزجه&nbsp;في الماء.</p><p>المكونات الأخرى: سكر فيتزمايلد ؛ مانيتول؛ السكرين الصوديوم؛ الأسبارتام؛ كربونات البوتاسيوم ؛ مسحوق نكهة النعناع ؛ مسحوق نكهة اليانسون ؛ كحول 95</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>حبيبات تأتي في مغلفات مربعة الشكل كل كرتون يحتوي على 10 مغلفات</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr">الجزيرة للصناعات الدوائية (JPI)<br />الرياض، المملكة العربية السعودية، الرياض 11666 ، صندوق البريد 106229<br />+966-11-207- رقم الهاتف: 8172<br />+966-11-207- فاكس: 8097<br /><u>medical@jpi.com.sa </u>: البريد الإلكتروني</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على ھذه النشرة الأخیرة في2014/4 ، رقم النسخة 1.1 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oflam® 50mg Granules for oral solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each sachet contains 50 mg of diclofenac potassium
Chemical name: Potassium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Granules for oral solution
− Appearance as powder: white to yellowish powder with peppermint smell
− After reconstitution: white to yellowish solution containing a few suspended particles with characteristic peppermint odor.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute Treatment of Migraine<br />OFLAM (Diclofenac Potassium for Oral Solution) is indicated for the acute treatment of migraine attacks with or without aura in adults (18 years of age or older).<br /><strong>Important Limitations</strong></p><ul><li>OFLAM granules is not indicated for the prophylactic therapy of migraine.</li><li>The safety and effectiveness of OFLAM have not been established for cluster headache, which is present in an older, predominantly male population.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><strong>Acute Treatment of Migraine:</strong> Administer one sachet (50 mg) of OFLAM for the acute treatment of migraine. Empty the contents of one sachet into a cup containing 1 to 2 ounces (30 to 60 mL) of water, mix well and drink immediately. Do not use liquids other than water.<br />Taking OFLAM with food may cause a reduction in effectiveness compared to taking OFLAM on an empty stomach (see section 5.2 Pharmacokinetic properties)<br />Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. The safety and effectiveness of a second dose have not been established.<br />For preparation of sachet for oral use see section 6.6</p><p><strong>Interchangeability With Other Formulations of Diclofenac</strong><br />Different formulations of oral diclofenac (e.g., OFLAM, diclofenac sodium enteric-coated tablets, diclofenac sodium extended-release tablets, or diclofenac potassium immediate-release tablets) may not be bioequivalent even if the milligram strength is the same. Therefore, it is not possible to convert dosing from any other formulation of diclofenac to OFLAM.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or any of the excipients.
• Active, gastric or intestinal ulcer, bleeding or perforation.
• History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy
• Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
• Last trimester of pregnancy (see section 4.6 Pregnancy and lactation).
• Severe hepatic, renal or cardiac failure (see section 4.4 Special warnings and precautions for use).
• Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angioedema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.
• Established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong><br />Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 Posology and method of administration and GI and cardiovascular risks below).</p><p>The concomitant use of Oflam with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see section 4.2 Posology and Method of administration).</p><p>As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur without earlier exposure to the drug (see section 4.8 Undesirable effects).</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of the infection due to its pharmacodynamic properties.</p><p>Oflam granules 50mg contain Aspartame and therefore are not recommended for patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.</p><p><strong>Gastrointestinal effects:</strong><br />Gastrointestinal bleeding (haematemesis, melaena) ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac and may occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. They<br />generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the drug should be withdrawn.</p><p>As with all NSAIDs, including diclofenac close medical surveillance is imperative and particular caution should be excised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders, or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8 Undesirable effects). The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation.</p><p>The elderly have increased frequency of adverse reactions to NSAIDs especially gastro intestinal bleeding and perforation which may be fatal (see section 4.2 Posology and method of administration).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin or medicinal products likely to increase gastrointestinal risk. (See section 4.5 Interactions with other medicaments and other forms of interaction).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding).</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5 Interaction with other medicaments and other forms of interaction).</p><p>Close medical surveillance and caution should be exercised in patients with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated (see section 4.8 Undesirable effects).</p><p><strong>Hepatic effects:</strong><br />Close medical surveillance is required when prescribing Oflam to patients with impairment of hepatic function as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with Diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure.</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), Oflam should be discontinued.</p><p>Hepatitis may occur with diclofenac without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p><strong>Renal effects:</strong><br />As fluid retention and oedema have been reported in association with NSAIDs therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see section 4.3 Contraindications). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation therapy is usually followed by recovery to the pre-treatment state.</p><p><strong>Skin effects:</strong><br />Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including Oflam (see section 4.8 Undesirable effects). Patients appear to be at the highest risk of these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Oflam should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.</p><p><strong>SLE and mixed connective tissue disease:</strong><br />In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8 Undesirable effects).</p><p><strong>Cardiovascular and cerebrovascular effects:</strong><br />Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration. As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy, including diclofenac.</p><p>Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with diclofenac after careful consideration.</p><p><strong>Haematological effects:</strong><br />Use of Oflam are recommended only for short term treatment.</p><p>During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>Diclofenac may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5 Interaction with other medicaments and other forms of interactions). Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored.</p><p><strong>Pre-existing asthma:</strong><br />In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so called intolerance to analgesics / analgesics asthma), Quincke&#39;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma.</p><p><strong>Female fertility:</strong><br />The use of Diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Diclofenac should be considered (see section 4.6 Pregnancy and Lactation).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac and/or other pharmaceutical forms of diclofenac.</p><p><strong>Lithium: </strong>If used concomitantly, Oflam may increase plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p><strong>Digoxin:</strong> If used concomitantly, Oflam may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p><strong>Diuretics and antihypertensive agents:</strong> Like other NSAIDs, concomitant use of Oflam with diuretics and antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.</p><p>Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity (see section 4.4 Special warnings and precautions for use).</p><p><strong>Drugs known to cause hyperkalemia: </strong>Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4 Special warnings and precautions for use).</p><p><strong>Anticoagulants and anti-platelet agents: </strong>Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4 Special warnings and precautions for use). Although clinical investigations do not appear to indicate that Oflam has an influence on the effect of anticoagulants, there are isolated reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulant concomitantly (see section 4.4 Special warnings and precautions for use). Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required. As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation.</p><p><strong>Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids: </strong>Co-administration of diclofenac with other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs (see section 4.4 Special warnings and precautions for use).</p><p><strong>Selective serotonin reuptake inhibitors (SSRIs): </strong>Concomitant administration of SSRI&#39;s may increase the risk of gastrointestinal bleeding (see section 4.4 Special warnings and precautions for use).</p><p><strong>Antidiabetics: </strong>Clinical studies have shown that Oflam can be given together with oral antidiabetic agents without influencing their clinical effect. However there have been isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><strong>Methotrexate:</strong> Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increase. Cases of serious toxicity have been reported when methotrexate and NSAIDs, including diclofenac are given within 24 hours of each other. This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p><strong>Ciclosporin:</strong> Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p><strong>Tacrolimus: </strong>Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p><p><strong>Quinolone antibacterials: </strong>Convulsions may occur due to an interaction between quinolones and NSAIDs. This may occur in patients with or without a previous history of epilepsy or convulsions. Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><strong>Phenytoin: </strong>When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p><strong>Colestipol and cholestyramine: </strong>These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/ cholestyramine.</p><p><strong>Cardiac glycosides: </strong>Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><strong>Mifepristone: </strong>NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p><strong>Potent CYP2C9 inhibitors:</strong> Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy:</strong> Pregnancy Category C</p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and or cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1% up to approximately 1.5%.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has shown to result in increased pre-and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during organogenetic period. If Oflam is used by a woman attempting to conceive, or during the 1st trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:<br />-&nbsp; cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension)<br />-&nbsp; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis</p><p>The mother and the neonate, at the end of the pregnancy, to:<br />-&nbsp; possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses<br />-&nbsp; inhibition of uterine contractions resulting in delayed or prolonged labour</p><p>Consequently, Oflam is contraindicated during the third trimester of pregnancy.</p><p><strong>Lactation</strong></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore, Diclofenac should not be administered during breast feeding in order to avoid undesirable effects in the infant (see section 5.2 Pharmacokinetic properties).</p><p><strong>Female fertility</strong></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered. See also section 4.4 Special warnings and precautions for use, regarding female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, vertigo, somnolence, central nervous system disturbances, drowsiness or fatigue while taking NSAIDs should refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common (&ge; 1/100, &lt;1/10); uncommon (&ge; 1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1000); very rare (&lt;1/10,000); not known: cannot be estimated from available data.<br />The following undesirable effects include those reported with other short-term or long-term use.<br /><strong>Table 1</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:695px"><tbody><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Blood and lymphatic system disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Thrombocytopenia, leucopoenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Immune system disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Angioneurotic oedema (including face oedema).</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Psychiatric disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Nervous system disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top; width:619px"><p>Headache, dizziness.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Somnolence, tiredness.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p></td></tr><tr><td style="vertical-align:top"><p>Unknown</p></td><td style="vertical-align:top; width:619px"><p>Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Eye disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Visual disturbance, vision blurred, diplopia.</p></td></tr><tr><td style="vertical-align:top"><p>Unknown</p></td><td style="vertical-align:top; width:619px"><p>Optic neuritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Ear and labyrinth disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top; width:619px"><p>Vertigo.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Cardiac disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Palpitations, chest pain, cardiac failure, myocardial infarction.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Vascular disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Respiratory, thoracic and mediastinal disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Asthma (including dyspnoea).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Gastrointestinal disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top; width:619px"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly).</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Hepatobiliary disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top; width:619px"><p>Transaminases increased.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Hepatitis, jaundice, liver disorder.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Skin and subcutaneous tissue disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top; width:619px"><p>Rash.</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Urticaria.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura, allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Renal and urinary disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>General disorders and administration site conditions </strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top; width:619px"><p>Oedema</p></td></tr><tr><td colspan="2" style="vertical-align:top; width:692px"><p><strong>Reproductive system and breast disorders </strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top; width:619px"><p>Impotence.</p></td></tr></tbody></table><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high doses (150mg daily) and in long term treatment (see sections 4.3 and 4.4 for Contraindications and Special warnings and special precautions for use).<br /><strong><u>Reporting of suspected adverse reactions</u></strong></p><ul><li><strong>&nbsp;Saudi Arabia:</strong></li></ul><p>&minus; The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: <u>npc.drug@sfda.gov.sa</u><br />Website: <u>www.sfda.gov.sa/npc</u><br /><strong>&bull; Other GCC States:</strong> Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Symptoms</strong><br />There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting, or convulsions. In the case of significant poisoning acute renal failure and liver damage are possible.</p><p><strong>Therapeutic measures</strong><br />Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to high protein binding and extensive metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Nonsteroidal anti-inflammatory drug (NSAID).</p><p>Oflam granules contain the potassium salt of diclofenac, a nonsteroidal compound with pronounced and clinically demonstrable analgesic, anti-inflammatory and anti-pyretic properties.</p><p>Diclofenac is a potent inhibitor of prostaglandin bio-synthesis and modulator of arachidonic acid release and uptake.</p><p>Oflam granules have a rapid onset of action and are therefore suitable for the treatment of acute episodes of pain and inflammation.</p><p>In migraine attacks Oflam has been shown to be effective in relieving the headache and in improving the accompanying symptom of nausea.</p><p>Diclofenac<em> in vitro</em> does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><em>Absorption: </em></u>Diclofenac is 100% absorbed after oral administration compared to intravenous administration as measured by urine recovery. However, due to first-pass metabolism, only about 50% of the absorbed dose is systemically available. In fasting volunteers, measurable plasma levels were observed within 5 minutes of dosing with CAMBIA. Peak plasma levels were achieved at approximately 0.25 hour in fasting normal volunteers, with a range of 0.17 to 0.67 hours. High fat food had no significant effect on the extent of diclofenac absorption, but there was a reduction in peak plasma levels of approximately 70% after a high fat meal. Decreased Cmax may be associated to decreased effectiveness.</p><p><u><em>Distribution:</em></u> The apparent volume of distribution (V/F) of diclofenac potassium is 1.3 L/kg.</p><p>Diclofenac is more than 99% bound to human serum proteins, primarily to albumin. Serum protein binding is constant over the concentration range (0.15-105 &mu;g/mL) achieved with recommended doses.</p><p><u><em>Metabolism:</em></u> Five diclofenac metabolites have been identified in human plasma and urine. The metabolites include 4&#39;-hydroxy-, 5-hydroxy-, 3&#39;-hydroxy-, 4&#39;,5-dihydroxy- and 3&#39;-hydroxy-4&#39;-methoxy diclofenac. The major diclofenac metabolite, 4&rsquo;-hydroxydiclofenac, has very weak pharmacologic activity. The formation of 4&rsquo;-hydroxy diclofenac is primarily mediated by CPY2C9. Both diclofenac and its oxidative metabolites undergo glucuronidation or sulfation followed by biliary excretion. Acylglucuronidation mediated by UGT2B7 and oxidation mediated by CPY2C8 may also play a role in diclofenac metabolism. CYP3A4 is responsible for the formation of minor metabolites, 5-hydroxy and 3&rsquo;-hydroxy- diclofenac. In patients with renal impairment, peak concentrations of metabolites 4&#39;-hydroxy-and 5- hydroxydiclofenac were approximately 50% and 4% of the parent compound after single oral dosing compared to 27% and 1% in normal healthy subjects.</p><p><u><em>Excretion: </em></u>Diclofenac is eliminated through metabolism and subsequent urinary and biliary excretion of the glucuronide and the sulfate conjugates of the metabolites. Little or no free unchanged diclofenac is excreted in the urine. Approximately 65% of the dose is excreted in the urine and approximately 35% in the bile as conjugates of unchanged diclofenac plus metabolites. Because renal elimination is not a significant pathway of elimination for unchanged diclofenac, dosing adjustment in patients with mild to moderate renal dysfunction is not necessary. The terminal half-life of unchanged diclofenac is approximately 2 hours.</p><p><u><em>Special Populations:</em></u><br />Race: There are no pharmacokinetic differences due to race.</p><p>Hepatic Impairment: The liver metabolizes almost 100% of diclofenac; there is insufficient information available to support dosing recommendations for CAMBIA in patients with hepatic insufficiency.</p><p>Renal Impairment: In patients with renal impairment (inulin clearance 60-90, 30-60, and &lt;30 mL/min; N=6 in each group), AUC values and elimination rate were comparable to those in healthy subjects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Relevant information on the safety of Oflam is included in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><ul><li>Sugar Fitzmilled</li><li>Mannitol</li><li>Sodium Saccharine</li><li>Aspartame</li><li>Potassium Bicarbonate</li><li>Peppermint Powder Flavor</li><li>Aniseed Powder Flavor</li><li>Alcohol 95</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in original packaging below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pack of 10 sachets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medicines should be kept out of the reach of children.</p><p>The content of the sachet is to be dissolved in a half glass of natural water preferably before meals. Possible opalescence of the solution does not indicate impairment in the efficacy of the preparation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries (JPI)
Riyadh, Saudi Arabia
11666 Riyadh, P.O.Box 106229
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                21 January 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>